Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7399805 | 0.89 | — | — | |
| Hydrochloric Acid SCHEMBL2077994 | 0.87 | — | — | |
| Hydrochloric Acid SCHEMBL5601204 | 0.87 | — | — | |
| Hydrochloric Acid SCHEMBL2262372 | 0.87 | — | — | |
| Hydrochloric Acid SCHEMBL11872108 | 0.87 | — | — | |
| Hydrochloric Acid SCHEMBL872660 | 0.87 | — | — | |
| Hydrochloric Acid SCHEMBL391864 | 0.87 | — | — | |
| SCHEMBL11501267 | 0.87 | — | — | |
| SCHEMBL10681926 | 0.75 | — | — | |
| Hydrochloric Acid SCHEMBL4914931 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113816956-A | Synthesis method of pexidaltinib | 湖北工业大学 | 2021-12-21 | — | — | CN | claimed |
| CN-113429342-A | Synthesis method of pexidaltinib intermediate | 武汉格迪泰健康科技有限公司 | 2021-09-24 | — | — | CN | claimed |
| CN-104230840-A | Synthesis method of mirabegron | ANHUI LIANCHUANG PHARMACEUTICAL CHEMISTRY CO LTD | 2014-12-24 | — | — | CN | claimed |
| CN-101619059-B | Method for preparing osemozotan hydrochloride | JIANGSU ENHUA PHARMACEUTICAL CO LTD | 2011-09-14 | — | — | CN | claimed |
| US-7714174-B2 | Lower-color polytrimethylene ether glycol using hydride compounds | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-05-11 | — | — | US | claimed |
| CN-101619059-A | Method for preparing osemozotan hydrochloride | NHWA PHARMACEUTICAL GROUP CO L | 2010-01-06 | — | — | CN | claimed |
| US-20080242830-A1 | Lower-color polytrimethylene ether glycol using hydride compounds | E. I. DU PONT DE NEMOURS AND COMPANY | 2008-10-02 | — | — | US | claimed |
| WO-2008118496-A1 | LOWER-COLOR POLYTRIMETHYLENE ETHER GLYCOL USING HYDRIDE COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-10-02 | — | — | WO | claimed |
| EP-0107988-B1 | IMIDAZO (1,2-A)QUINOLINES, THEIR SALTS, THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND COMPOSITIONS CONTAINING THEM | ROUSSEL-UCLAF (FR) | 1987-07-29 | — | — | EP | claimed |
| US-4423044-A | NERVOUS SYSTEM DISORDERS | EGYT GYOGYSZERVEGYESZETI GYAR (HU) | 1983-12-27 | — | — | US | claimed |
| EP-0002835-A1 | Aminoglycoside derivatives, process for their manufacture and pharmaceutical compositions | SHIONOGI & CO., LTD. (JP) | 1979-07-11 | — | — | EP | claimed |
| CN-113816956-A | Synthesis method of pexidaltinib | 湖北工业大学 | 2021-12-21 | — | — | CN | disclosed |
| CN-113429342-A | Synthesis method of pexidaltinib intermediate | 武汉格迪泰健康科技有限公司 | 2021-09-24 | — | — | CN | disclosed |
| EP-3322687-B1 | 2-BENZYL-INDANONE COMPOUNDS AS ANTICANCER AGENT AND A PROCESS FOR PREPARATION THEREOF | COUNCIL SCIENT IND RES (IN) | 2020-02-26 | — | — | EP | disclosed |
| CN-103012231-B | The preparation method and application of Glycopyrronium Bromide chiral enantiomer | SHENYANG PHARMACEUTICAL UNIVERSITY (CN) | 2015-08-05 | — | — | CN | disclosed |
| US-4009275-A | Phenoxypropylamine derivatives | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-02-22 | — | — | US | disclosed |
| US-4003913-A | ANTIDEPRESSANTS, ANTIULCER AGENTS | AYERST MCKENNA AND HARRISON LTD. (CA) | 1977-01-18 | — | — | US | disclosed |
| US-3995052-A | Indenopyran- and indenothiopyranalkylamines III in the treatment of depression | AYERST MCKENNA AND HARRISON LTD. (CA) | 1976-11-30 | — | — | US | disclosed |
| US-RE28973-E | PARKINSON'S DISEASE | A. H. ROBINS COMPANY, INCORPORATED (US) | 1976-09-21 | — | — | US | disclosed |
| US-3962236-A | ANTIDEPRESSANTS, ANTI-ULCER | AYERST MCKENNA AND HARRISON LTD. (CA) | 1976-06-08 | — | — | US | disclosed |